Vyant Bio (OTCMKTS:VYNT) Trading Up 7.8%

Vyant Bio, Inc. (OTCMKTS:VYNTGet Free Report) shot up 7.8% during trading on Monday . The company traded as high as $0.20 and last traded at $0.19. 19,100 shares were traded during mid-day trading, a decline of 88% from the average session volume of 161,822 shares. The stock had previously closed at $0.18.

Vyant Bio Stock Up 7.8 %

The company has a 50 day simple moving average of $0.19 and a two-hundred day simple moving average of $0.19. The company has a quick ratio of 2.86, a current ratio of 2.86 and a debt-to-equity ratio of 0.04.

Vyant Bio Company Profile

(Get Free Report)

Vyant Bio, Inc, a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD).

Further Reading

Receive News & Ratings for Vyant Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vyant Bio and related companies with MarketBeat.com's FREE daily email newsletter.